Sunil Healthcare Board of Directors
Get the latest insights into the leadership at Sunil Healthcare. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Satyendu Pattnaik | Company Secretary & Compliance Officer, DGM Legal |
| Anil Khaitan | Chairman & Managing Director, Chief Executive Officer |
| Rakesh Mohan | Non Executive Independent Director |
| Sanjay Kumar Kaushik | Non Independent & Non Executive Director |
| Harish Pal Kumar | Non Executive Independent Director |
| Krishna Venkatachalam Rajan | Non Independent & Non Executive Director |
| Bejon Kumar Misra | Non Executive Independent Director |
| Jai Prakash Singh | Non Executive Independent Director |
| Mudita Chaturvedi | Non Executive Independent Director |
Sunil Healthcare FAQs
The board at Sunil Healthcare consists of experienced professionals, including Satyendu Pattnaik, Anil Khaitan, and others, overseeing the company’s strategic and corporate governance.
Directors at Sunil Healthcare are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Satyendu Pattnaik is the current chairman at Sunil Healthcare.
Executive directors at Sunil Healthcare are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Sunil Healthcare adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Sunil Healthcare, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
